News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
107,179 Results
Type
Article (16263)
Company Profile (23)
Press Release (90893)
Section
Business (31419)
Career Advice (1010)
Deals (5835)
Drug Delivery (78)
Drug Development (13474)
Employer Resources (149)
FDA (2725)
Job Trends (3816)
News (53088)
Policy (5130)
Tag
2024 BioMidwest Digital (1)
2024 Bio NC Digital (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (2)
2026 Genetown Elite (1)
Academia (669)
Academic (1)
Accelerated approval (3)
Adcomms (7)
Allergies (16)
Alliances (8076)
ALS (22)
Alzheimer's disease (376)
Antibody-drug conjugate (ADC) (65)
Approvals (2687)
Artificial intelligence (101)
Autoimmune disease (9)
Automation (1)
Bankruptcy (65)
Best Places to Work (2058)
BIOSECURE Act (12)
Biosimilars (44)
Biotechnology (14)
Bladder cancer (31)
Brain cancer (10)
Breast cancer (58)
Cancer (498)
Cardiovascular disease (65)
Career advice (863)
Career pathing (29)
CAR-T (48)
Cell therapy (129)
Cervical cancer (8)
Clinical research (10389)
Collaboration (199)
Compensation (30)
Complete response letters (5)
COVID-19 (773)
CRISPR (16)
C-suite (70)
Cystic fibrosis (33)
Data (416)
Decentralized trials (2)
Denatured (43)
Depression (24)
Diabetes (74)
Diagnostics (1207)
Digital health (3)
Diversity (9)
Diversity, equity & inclusion (41)
Drug discovery (48)
Drug pricing (54)
Drug shortages (21)
Duchenne muscular dystrophy (36)
Earnings (7802)
Editorial (29)
Employer branding (22)
Employer resources (125)
Events (12421)
Executive appointments (193)
FDA (2907)
Featured Employer (5)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (191)
Gene editing (37)
Generative AI (14)
Gene therapy (120)
GLP-1 (374)
Government (1089)
Grass and pollen (2)
Guidances (8)
Healthcare (3434)
Huntington's disease (10)
IgA nephropathy (13)
Immunology and inflammation (51)
Indications (6)
Infectious disease (814)
Inflammatory bowel disease (34)
Inflation Reduction Act (10)
Influenza (2)
Intellectual property (18)
Interviews (156)
IPO (1776)
IRA (28)
Job creations (1754)
Job search strategy (745)
Kidney cancer (2)
Labor market (36)
Layoffs (232)
Leadership (11)
Legal (1102)
Liver cancer (17)
Lung cancer (91)
Lymphoma (21)
Machine learning (3)
Management (43)
Manufacturing (116)
MASH (18)
Medical device (2180)
Medtech (2181)
Mergers & acquisitions (4148)
Metabolic disorders (273)
Multiple sclerosis (12)
NASH (11)
Neurodegenerative disease (37)
Neuropsychiatric disorders (16)
Neuroscience (521)
NextGen: Class of 2025 (1665)
Non-profit (869)
Northern California (379)
Now hiring (34)
Obesity (164)
Opinion (149)
Ovarian cancer (7)
Pain (24)
Pancreatic cancer (14)
Parkinson's disease (33)
Partnered (13)
Patents (46)
Patient recruitment (14)
Peanut (6)
People (10925)
Pharmaceutical (5)
Pharmacy benefit managers (5)
Phase I (2925)
Phase II (4374)
Phase III (4696)
Pipeline (268)
Podcasts (117)
Policy (75)
Postmarket research (344)
Preclinical (1252)
Press Release (33)
Prostate cancer (25)
Psychedelics (23)
Radiopharmaceuticals (72)
Rare diseases (141)
Real estate (2574)
Recruiting (53)
Regulatory (3392)
Reports (47)
Research institute (622)
Resumes & cover letters (164)
RNA editing (2)
RSV (13)
Schizophrenia (25)
Series A (57)
Series B (25)
Service/supplier (3)
Sickle cell disease (15)
Southern California (293)
Special edition (18)
Spinal muscular atrophy (31)
Sponsored (18)
Startups (1098)
State (1)
Stomach cancer (4)
Supply chain (23)
The Weekly (72)
United States (3378)
Vaccines (246)
Venture capitalists (25)
Webinars (10)
Weight loss (161)
Women's health (20)
Worklife (16)
Date
Today (22)
Last 7 days (122)
Last 30 days (522)
Last 365 days (6760)
2025 (1705)
2024 (6869)
2023 (7062)
2022 (11201)
2021 (11691)
2020 (10004)
2019 (8554)
2018 (6281)
2017 (6265)
2016 (5963)
2015 (6746)
2014 (4378)
2013 (2710)
2012 (2728)
2011 (3074)
2010 (2390)
Location
Africa (349)
Alabama (8)
Arizona (18)
Arkansas (1)
Asia (5717)
Australia (1000)
California (814)
Canada (222)
China (91)
Colorado (38)
Connecticut (43)
Delaware (19)
Europe (18261)
Florida (157)
Georgia (55)
Idaho (10)
Illinois (98)
India (8)
Indiana (55)
Iowa (7)
Japan (27)
Kansas (16)
Kentucky (3)
Louisiana (4)
Maine (3)
Maryland (105)
Massachusetts (677)
Michigan (65)
Minnesota (58)
Missouri (9)
Montana (3)
Nebraska (7)
Nevada (11)
New Hampshire (8)
New Jersey (329)
New Mexico (11)
New York (230)
North Carolina (150)
North Dakota (1)
Northern California (379)
Ohio (26)
Oklahoma (3)
Oregon (19)
Pennsylvania (181)
Puerto Rico (2)
Rhode Island (5)
South America (412)
South Carolina (3)
South Dakota (1)
Southern California (293)
Tennessee (12)
Texas (121)
Utah (32)
Virginia (33)
Washington D.C. (10)
Washington State (62)
West Virginia (2)
Wisconsin (12)
107,179 Results for "theramex spa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Daré Bioscience and Theramex Announce Co-Development and Licensing Agreement for a Potential Biodegradable Long-Acting Contraceptive Implant
February 21, 2025
·
10 min read
Deals
Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.
Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, is pleased to announce that it has entered into an agreement to acquire the European rights to Duphaston® and Femoston® from Viatris Inc.
October 10, 2023
·
1 min read
Press Releases
Bioxytran Secures $1.6 million SPA to Extinguish Note & Fund Clinical Development
January 23, 2025
·
4 min read
Press Releases
Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
January 14, 2025
·
4 min read
Press Releases
Axxam S.p.A. accelerates global expansion incorporating Axxam Inc.
December 13, 2024
·
2 min read
Press Releases
Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A
December 3, 2024
·
5 min read
Deals
Donaldson Enters into Agreement to Acquire Minority Stake in Medica, S.p.A.
Donaldson Company, Inc., a leading worldwide provider of innovative filtration products and solutions, announced it has entered into a definitive agreement allowing the Company to purchase a 49% stake in Medica S.p.A.
April 29, 2024
·
5 min read
Press Releases
Precision X-Ray, Inc. Partners with Gilardoni SpA to Deliver X-Ray Blood Irradiation in the US
October 16, 2024
·
2 min read
Deals
Enovis Completes Acquisition of LimaCorporate S.p.A
Enovis™ Corporation an innovation-driven, medical technology growth company, announced that it closed the acquisition of LimaCorporate S.p.A., a privately held global orthopedic leader focused on restoring motion through an innovative portfolio of implant solutions.
January 3, 2024
·
3 min read
Deals
Quince Therapeutics Completes Acquisition of EryDel S.p.A.
Quince Therapeutics, Inc. announced the successful completion of its acquisition of EryDel S.p.A., a privately-held, late-stage biotech company.
October 23, 2023
·
6 min read
1 of 10,718
Next
